JOIN OUR TEAM
Driven by the market return of popular OTC brands from Johnson & Johnson and GlaxoSmithKline, as well as the success of several Rx-to-OTC switch brands, the U.S. OTC market increases by a solid 4% in 2015, reveals our recently published Nonprescription Drugs USA report. In October 2015, Johnson & Johnson announced that the FDA approved
Over the past several years, the U.S. market for probiotics has emerged as one of the fastest growing consumer healthcare markets, consistently achieving double-digit sales growth. In 2015, according to our recently published Nonprescription Drugs USA and Natural OTCs: Impact of Non-drug Products on the U.S. OTC Market studies, the total market for probiotics is
The U.S. market for nutritional supplements and wellness products is massive and valued at over $30 billion in annual retail sales. This remains an area that elicits strong consumer interest as people seek to preserve and improve their health and avoid illness. Products like digestive enzymes, vitamins and minerals, weight loss and management systems, and
Chronic pain continues to be an area consumers seek to treat with a variety of methods including prescription drugs, OTC medications, topical rubs, and pain management devices. The increasing U.S. aging population will continue to generate the demand for pain relief products. Seniors increasingly seek to mitigate pain associated with old age and sedentary lifestyles,
While the U.S. OTC market is not highly dynamic in terms of growth, its competitive landscape has changed significantly over the past five years, with the top 10 rankings shifting in 2015. Market leaders Johnson & Johnson and Bayer have remained the #1 and #2 OTC marketers, respectively, for many years. Bayer’s bolt-on acquisition of
In June 2009, the U.S. Congress passed the Family Smoking Prevention & Tobacco Control Act, which gave the U.S. Food & Drug Administration (FDA) authority to regulate the manufacturing, distribution, and marketing of tobacco products. On June 16, 2016, a new rule was passed extending the FDA’s regulatory authority to all tobacco products, including e-cigarettes,
Major mergers and acquisitions in the U.S. OTC market have a way of shifting OTC cost structures both in the near- and long-term. For example, when major businesses are merged, such as Bayer Group’s acquisition of Merck’s U.S. OTC business or when GlaxoSmithKline and Novartis formed a consumer healthcare joint venture, the costs of goods
Driven by the solid growth of most markets, sales of the U.S. OTC market increase by 3% in 2015. Particularly high gains are seen in the allergy and antacids markets, fueled by recent Rx-to-OTC switch brands, such as Flonase Allergy Relief by GlaxoSmithKline and Nexium 24HR by Pfizer. Recently released sales data from our annual
The U.S. OTC allergy relief market has seen a period of rapid growth over the past five years, and 2015 was no exception. GlaxoSmithKline’s Rx-to-OTC switch brand Flonase Allergy Relief entered the market in February 2015 and made a huge impact on the OTC market by adding previous prescription users to the category. The OTC
While pain management devices are not something brand new on the market—for example, transcutaneous electrical nerve stimulation (TENS) technology has existed for over 50 years—the market is witnessing a revolution thanks to the introduction of products like IcyHot SmartRelief TENS Therapy by the French player Sanofi, which has made pain management products more accessible and
